Vivos Therapeutics, Inc. VVOS
Set alert
0.11 USD -0.01 -4.83%
At close
0.11 0.00 -2.68%
Pre-market · Nov 3, 6:38 AM ET
0.1081 Day range 0.1192
0.108 52-week range 2.72
- YTD
- -94.67%
- 1 year
- -95.80%
- Open
- 0.114
- Prev close
- 0.1138
- Mkt cap
- 3.64M
- Vol
- 617.17K
- Avg vol
- 15.04M
- EPS
- -1.88
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1081
- High
- 0.1192
- Forward P/E
- -9.31
- Beta
- 7.68
- Short ratio
- 0.66
- Inst. own
- 13.72%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 3.32
- 200-d avg
- 2.88
- 1y target
- 6.30
5D chart
Signals (132)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 12:25 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 12:20 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 12:20 PM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 12:10 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 11:55 AM | 19 hours ago |
| SMA: Bullish | Nov 2, 11:55 AM | 19 hours ago |
| SMA: Bearish | Nov 2, 11:40 AM | 19 hours ago |
| SMA: Bearish | Nov 2, 11:25 AM | 19 hours ago |
| SMA: Bullish | Nov 2, 11:20 AM | 19 hours ago |
| SMA: Bearish | Nov 2, 11:00 AM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 11:00 AM | 19 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 10:20 AM | 20 hours ago |
| SMA: Bearish | Nov 2, 10:15 AM | 20 hours ago |
| SMA: Bullish | Nov 2, 10:10 AM | 20 hours ago |
| SMA: Bearish | Nov 2, 10:05 AM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 10:05 AM | 20 hours ago |
| SMA: Bullish | Nov 2, 9:55 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 21 hours ago |
| RSI: Overbought | Nov 2, 9:30 AM | 21 hours ago |
Newest 20 of 132.
Analyst view
Consensus: none
Price target (mean) 6.30 +5717.2% upside
Now 0.1083
- Target (low)
- 6.00
- Target (mean)
- 6.30
- Target (high)
- 6.60
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.43 | -0.43 – -0.43 | -2.76 | +84.4% | 3.89M | +19.6% | 1 |
| Next quarter | -0.41 | -0.41 – -0.41 | -1.63 | +74.9% | 4.10M | +19.9% | 1 |
| Current year | -1.79 | -1.79 – -1.79 | -14.24 | +87.4% | 15.20M | +10.2% | 1 |
| Next year | -1.43 | -1.43 – -1.43 | -1.79 | +20.1% | 19.16M | +26.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2024 | Ascendiant Capital | Reiterated | Buy | Buy |
| Nov 19, 2024 | Alliance Global Partners | Maintained | Buy | Buy |
| Aug 20, 2024 | Ascendiant Capital | Maintained | Buy | Buy |